Literature DB >> 9692935

Advances in global measles control and elimination: summary of the 1997 international meeting.

.   

Abstract

A meeting concerning advances in measles control and elimination, the third in a series, was held in Atlanta during August 1997. The meeting was cosponsored by CDC, the Pan American Health Organization, the World Health Organization, and the United Nations Children's Fund. Meeting participants concluded that substantial progress has been made toward controlling measles. Measles transmission has been interrupted in several countries, reinforcing the view that measles eradication is technically feasible using existing vaccines and intervention strategies. However, measles still accounts for 10% of global mortality from all causes among children aged <5 years (i.e., approximately 1 million deaths annually). Progress toward measles control varies substantially among countries and regions. Intensified efforts are necessary to implement appropriate control and elimination strategies, including supplementary vaccination campaigns, expansion of routine vaccination services, and surveillance. These strategies and estimates of the resources required to implement them will require adjustment based on accumulating experience. Programmatic and financial obstacles must be overcome if the final goal of measles eradication is to be achieved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692935

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  10 in total

Review 1.  Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Virology       Date:  2011-01-08       Impact factor: 3.616

2.  Protective immunity following vaccination: how is it defined?

Authors:  Ian J Amanna; Ilhem Messaoudi; Mark K Slifka
Journal:  Hum Vaccin       Date:  2008-02-19

3.  Role of clinicians and public health professionals for measles surveillance in Canada.

Authors:  G A Tipples
Journal:  Paediatr Child Health       Date:  1999-01       Impact factor: 2.253

4.  No evidence of infectious retroviruses in measles virus vaccines produced in chicken embryo cell cultures.

Authors:  M Shahabuddin; J F Sears; A S Khan
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals.

Authors:  M Petrovic; R Roberts; M Ramsay
Journal:  BMJ       Date:  2001-01-13

6.  Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles.

Authors:  S Ratnam; G Tipples; C Head; M Fauvel; M Fearon; B J Ward
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Evidence of avian leukosis virus subgroup E and endogenous avian virus in measles and mumps vaccines derived from chicken cells: investigation of transmission to vaccine recipients.

Authors:  S X Tsang; W M Switzer; V Shanmugam; J A Johnson; C Goldsmith; A Wright; A Fadly; D Thea; H Jaffe; T M Folks; W Heneine
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Burden of illness in the first 3 years of life in an Indian slum.

Authors:  Beryl P Gladstone; Ashima R Das; Andrea M Rehman; Shabbar Jaffar; Mary K Estes; Jayaprakash Muliyil; Gagandeep Kang; Anuradha Bose
Journal:  J Trop Pediatr       Date:  2009-12-22       Impact factor: 1.165

9.  Simultaneous detection of measles virus, rubella virus, and parvovirus B19 by using multiplex PCR.

Authors:  María del Mar Mosquera; Fernando de Ory; Mónica Moreno; Juan E Echevarría
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 10.  Vitamin A for treating measles in children.

Authors:  Y Huiming; W Chaomin; M Meng
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.